Update to the optimal list of paediatric ARV formulations

Meeting Report, 11-12 Sept. 2013, Geneva, Switzerland

Interagency Task Team on Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and their Children, 2014

19 pp. 523 kB:
http://www.emtct-iatt.org/wp-content/uploads/2014/04/IATT-Sept-2013-Updated-Paediatric-ART-Formulary-Report3.pdfBild 001_resize

The antiretroviral treatment (ART) of HIV infection in paediatric populations is associated with a complex set of clinical, operational, and procurement challenges, particularly in resource-limited settings. The reliable delivery of high quality, affordable, paediatric-adapted ARVs is a prerequisite for the timely identification, initiation, and treatment of infected children. Currently, children account for fewer than 7% of all individuals on treatment, and as a result, the global paediatric ARV market is both smaller and more vulnerable to supply disruptions compared to the adult ARV market.

(Visited 24 times, 1 visits today)
This entry was posted in Essential Medicines, General, HIV - AIDS - STI. Bookmark the permalink.